DE69232615D1 - Zusammensetzungen zur verhütung und/oder behandlung von pathologischen prozessen - Google Patents
Zusammensetzungen zur verhütung und/oder behandlung von pathologischen prozessenInfo
- Publication number
- DE69232615D1 DE69232615D1 DE69232615T DE69232615T DE69232615D1 DE 69232615 D1 DE69232615 D1 DE 69232615D1 DE 69232615 T DE69232615 T DE 69232615T DE 69232615 T DE69232615 T DE 69232615T DE 69232615 D1 DE69232615 D1 DE 69232615D1
- Authority
- DE
- Germany
- Prior art keywords
- lmwh
- present
- prevention
- treatment
- pathological processes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Auxiliary Devices For And Details Of Packaging Control (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL9802891A IL98028A (en) | 1991-05-02 | 1991-05-02 | Pharmaceuticals containing low molecular weight heparin (HWML) |
IL98298A IL98298A0 (en) | 1991-05-28 | 1991-05-28 | Pharmaceutical compositions comprising a heparin derivative |
PCT/US1992/003626 WO1992019249A1 (en) | 1991-05-02 | 1992-05-01 | Compositions for the prevention and/or treatment of pathological processes |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69232615D1 true DE69232615D1 (de) | 2002-06-27 |
DE69232615T2 DE69232615T2 (de) | 2003-01-30 |
Family
ID=26322260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69232615T Expired - Lifetime DE69232615T2 (de) | 1991-05-02 | 1992-05-01 | Zusammensetzungen zur verhütung und/oder behandlung von pathologischen prozessen |
Country Status (15)
Country | Link |
---|---|
US (3) | US5474987A (de) |
EP (1) | EP0583360B1 (de) |
JP (1) | JPH06507635A (de) |
KR (1) | KR100235782B1 (de) |
AT (1) | ATE217796T1 (de) |
AU (1) | AU668865B2 (de) |
BR (1) | BR9205961A (de) |
CA (1) | CA2102207A1 (de) |
CZ (1) | CZ232593A3 (de) |
DE (1) | DE69232615T2 (de) |
FI (1) | FI934849A (de) |
HU (1) | HUT67136A (de) |
NO (1) | NO933942L (de) |
SK (1) | SK120193A3 (de) |
WO (1) | WO1992019249A1 (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5605938A (en) | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
US6750207B1 (en) * | 1992-05-01 | 2004-06-15 | Yeda Research And Development Co. Ltd. | Compositions for the regulation of cytokine activity |
AU686581B2 (en) * | 1992-11-10 | 1998-02-12 | Yeda Research And Development Co. Ltd. | Compositions for the regulation of cytokine activity |
AU6204594A (en) * | 1993-02-22 | 1994-09-14 | Ulrich-Christoph Von Arnim | Use of heparins for the treatment of inflammatory or immunological diseases |
US5980865A (en) * | 1995-08-18 | 1999-11-09 | Baker Norton Pharmaceuticals, Inc. | Method for treating late phase allergic reactions and inflammatory diseases |
CA2235223A1 (en) | 1995-10-30 | 1997-05-09 | Massachusetts Institute Of Technology | Rationally designed polysaccharide lyases derived from heparinase i |
IL129877A (en) * | 1996-11-27 | 2004-08-31 | Aventis Pharm Prod Inc | A pharmaceutical preparation containing a component having an Xa antagonist activity and an antifouling agent |
CN1287852C (zh) * | 1997-07-14 | 2006-12-06 | 村松乔 | 含有midkine或其抑制剂作为活性成分的药剂 |
CA2341412A1 (en) | 1998-08-27 | 2000-03-09 | Massachusetts Institute Of Technology | Rationally designed heparinases derived from heparinase i and ii |
US7056504B1 (en) | 1998-08-27 | 2006-06-06 | Massachusetts Institute Of Technology | Rationally designed heparinases derived from heparinase I and II |
IL127851A0 (en) * | 1998-12-30 | 1999-10-28 | Applied Research Systems | Inhibition of TNF activity |
US6597996B1 (en) * | 1999-04-23 | 2003-07-22 | Massachusetts Institute Of Technology | Method for indentifying or characterizing properties of polymeric units |
BR0012202A (pt) * | 1999-06-30 | 2002-04-02 | Hamilton Civic Hospitals Res | Composições de heparina de peso molecular médio (mmwh), método de tratamento de uma condição trombótica, método de prevenção da formação de um trombo, método de inibição da formação de trombos, composição farmacêutica, método de tratamento de trombose venosa profunda, método de prevenção de embolia pulmonar, método de preparação e usos de uma composição de mmwh |
AU4351201A (en) * | 2000-03-08 | 2001-09-17 | Massachusetts Inst Technology | Heparinase iii and uses thereof |
AU2001291549A1 (en) * | 2000-09-08 | 2002-03-22 | Hamilton Civic Hospitals Research Development Inc. | Antithrombotic compositions |
ES2324701T3 (es) * | 2000-09-12 | 2009-08-13 | Massachusetts Institute Of Technology | Metodos y productos relacionados con heparina de peso molecular bajo. |
WO2002032406A2 (en) | 2000-10-18 | 2002-04-25 | Massachusetts Institute Of Technology | Methods and products related to pulmonary delivery of polysaccharides |
CA2431709A1 (en) * | 2000-12-16 | 2002-06-20 | Aventis Pharma Deutschland Gmbh | Use of low molecular heparin for treating osteoarthritis |
EP1406571A4 (de) * | 2001-06-25 | 2007-05-30 | Depuy Int Ltd | Liposomale verkapselung von glycosaminoglycanen zur behandlung arthritischer gelenke |
WO2003011119A2 (en) * | 2001-07-31 | 2003-02-13 | Reddy Us Therapeutics, Inc. | Methods and compositions for diagnosis and treatment of vascular conditions |
EP1420820A4 (de) * | 2001-07-31 | 2005-04-06 | Univ Texas | Antigene von und antikörper gegen translozierte moleküle von mikroorganismen und ihre verwendungszwecke |
US7285536B2 (en) * | 2001-12-05 | 2007-10-23 | Yeda Research And Development Co., Ltd. | Anti-cancer therapeutic compounds |
US20040072796A1 (en) * | 2002-04-18 | 2004-04-15 | Embury Stephen H. | Method and composition for preventing pain in sickle cell patients |
US8071569B2 (en) * | 2002-09-20 | 2011-12-06 | Mousa Shaker A | Oxidized heparin fractions and their use in inhibiting angiogenesis |
WO2004067704A2 (en) | 2003-01-30 | 2004-08-12 | Prochon Biotech Ltd. | Freeze-dried fibrin matrices and methods for preparation thereof |
WO2005054493A2 (en) * | 2003-06-12 | 2005-06-16 | Mayo Foundation For Medical Education And Research | Altered activity of toll-like receptors |
JP4950660B2 (ja) | 2003-06-27 | 2012-06-13 | エチコン、インコーポレイテッド | 分娩後由来細胞を使用する眼組織の修復および再生 |
US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
WO2005032483A2 (en) * | 2003-10-01 | 2005-04-14 | Momenta Pharmaceuticals, Inc. | Polysaccharides for pulmonary delivery of active agents |
CN1819833A (zh) * | 2004-03-29 | 2006-08-16 | 克霖固鲁制药股份有限公司 | 促进hgf产生的含肝素类寡糖的药剂 |
US8450297B2 (en) * | 2004-08-16 | 2013-05-28 | Massachusetts Institute Of Technology | Rapid two-step synthesis of anti-coagulants |
PL1831356T3 (pl) | 2004-12-23 | 2017-07-31 | DePuy Synthes Products, Inc. | Komórki poporodowe pochodzące z tkanki pępowinowej i sposoby ich wytwarzania i stosowania |
MX2008000974A (es) * | 2005-07-22 | 2008-03-27 | Univ California | Composiciones de heparina e inhibicion de selectina. |
AU2006292224B2 (en) | 2005-09-19 | 2013-08-01 | Histogenics Corporation | Cell-support matrix and a method for preparation thereof |
AU2009250803A1 (en) * | 2008-05-20 | 2009-11-26 | Crystal Clear Partnership | Separation of polysaccharides by charge density gradient |
US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL61201A (en) * | 1979-10-05 | 1984-09-30 | Choay Sa | Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them |
US4281108A (en) * | 1980-01-28 | 1981-07-28 | Hepar Industries, Inc. | Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained |
EP0114589B1 (de) * | 1982-12-20 | 1987-09-23 | The President And Fellows Of Harvard College | Hemmung der Gefässneubildung |
US4916219A (en) * | 1985-03-28 | 1990-04-10 | University Of Iowa Research Foundation | Oligosaccharide heparin fragments as inhibitors of complement cascade |
IT1214609B (it) * | 1985-05-17 | 1990-01-18 | Opocrin Spa | Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono. |
US4889808A (en) * | 1985-10-01 | 1989-12-26 | American Home Products | Method of enchancing t-PA and SCU-PA production |
EP0240098A3 (de) * | 1986-04-04 | 1989-05-10 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Oligo und Polysaccharide zur Behandlung von Krankheiten verursacht durch Retroviren |
US4788307A (en) * | 1986-04-30 | 1988-11-29 | Choay S.A. | Oligosaccharidic fractions devoid or practically devoid of antithrombotic activity |
EP0245813B2 (de) * | 1986-05-16 | 2000-03-22 | ITALFARMACO S.p.A. | Heparine, frei von E.D.T.A., Fraktionen und Fragmente von Heparin, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, welche diese enthalten |
WO1988000017A1 (en) * | 1986-06-27 | 1988-01-14 | Boon Corporation Pty. Ltd. | Mat |
IL85145A (en) * | 1987-01-23 | 1994-08-26 | Univ Australian | Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity |
FR2614026B1 (fr) * | 1987-04-16 | 1992-04-17 | Sanofi Sa | Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques |
SE8702254D0 (sv) * | 1987-05-29 | 1987-05-29 | Kabivitrum Ab | Novel heparin derivatives |
WO1990003791A1 (en) * | 1988-10-05 | 1990-04-19 | Nicola Diferrante | Methods for interfering with hiv multiplication and composition for the treatment of aids |
IL88554A0 (en) * | 1988-12-01 | 1989-07-31 | Hadassah Med Org | Compositions containing a compound binding to a heparin receptor |
PT93847A (pt) * | 1989-04-24 | 1990-11-20 | Harvard College | Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem |
AT500533B8 (de) * | 2000-04-13 | 2007-02-15 | Man Nutzfahrzeuge Ag | Gas- oder trolleybus |
-
1992
- 1992-05-01 CZ CS932325A patent/CZ232593A3/cs unknown
- 1992-05-01 AT AT92911373T patent/ATE217796T1/de not_active IP Right Cessation
- 1992-05-01 JP JP4511483A patent/JPH06507635A/ja active Pending
- 1992-05-01 KR KR1019930703303A patent/KR100235782B1/ko not_active IP Right Cessation
- 1992-05-01 DE DE69232615T patent/DE69232615T2/de not_active Expired - Lifetime
- 1992-05-01 EP EP92911373A patent/EP0583360B1/de not_active Expired - Lifetime
- 1992-05-01 BR BR9205961A patent/BR9205961A/pt not_active Application Discontinuation
- 1992-05-01 WO PCT/US1992/003626 patent/WO1992019249A1/en active IP Right Grant
- 1992-05-01 HU HU9303110A patent/HUT67136A/hu unknown
- 1992-05-01 AU AU19131/92A patent/AU668865B2/en not_active Ceased
- 1992-05-01 SK SK1201-93A patent/SK120193A3/sk unknown
- 1992-05-01 CA CA002102207A patent/CA2102207A1/en not_active Abandoned
-
1993
- 1993-11-01 NO NO933942A patent/NO933942L/no unknown
- 1993-11-02 FI FI934849A patent/FI934849A/fi not_active Application Discontinuation
-
1995
- 1995-02-03 US US08/384,203 patent/US5474987A/en not_active Expired - Lifetime
- 1995-06-01 US US08/457,655 patent/US5686431A/en not_active Expired - Lifetime
-
1997
- 1997-11-07 US US08/966,315 patent/US5908837A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CZ232593A3 (en) | 1994-07-13 |
EP0583360B1 (de) | 2002-05-22 |
BR9205961A (pt) | 1994-07-26 |
NO933942L (no) | 1993-12-14 |
US5686431A (en) | 1997-11-11 |
NO933942D0 (no) | 1993-11-01 |
EP0583360A4 (de) | 1994-04-06 |
AU1913192A (en) | 1992-12-21 |
DE69232615T2 (de) | 2003-01-30 |
ATE217796T1 (de) | 2002-06-15 |
JPH06507635A (ja) | 1994-09-01 |
WO1992019249A1 (en) | 1992-11-12 |
HUT67136A (en) | 1995-02-28 |
US5908837A (en) | 1999-06-01 |
EP0583360A1 (de) | 1994-02-23 |
CA2102207A1 (en) | 1992-11-03 |
HU9303110D0 (en) | 1994-01-28 |
FI934849A0 (fi) | 1993-11-02 |
US5474987A (en) | 1995-12-12 |
AU668865B2 (en) | 1996-05-23 |
FI934849A (fi) | 1993-12-31 |
SK120193A3 (en) | 1994-07-06 |
KR100235782B1 (ko) | 1999-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69232615D1 (de) | Zusammensetzungen zur verhütung und/oder behandlung von pathologischen prozessen | |
ES2192667T3 (es) | Tratamiento de los trastornos de la artritis, artritis reumatica y manifestaciones asociadas con los trastornos reumaticos. | |
MD1507G2 (ro) | Inhibitori, compoziţie farmaceutică pe baza lor şi procedeu de inhibare a HIV proteazei | |
DK0781278T3 (da) | Nye benzothiepiner, som har aktivitet som inhibitorer af ileal galdsyretransport og taurocholatoptagelse | |
ATE218164T1 (de) | Hemmung der fortpflanzung von arterienglattmuskelzellen | |
DE69725860D1 (de) | PLAN ZUR VERABREICHUNG VON H+, K+-ATPase INHIBITOREN | |
TJ252B (en) | Benzothiophene benzofuran indolethiazepinone oxazepinone and diazepinone derivatives pharmaceutical composition having activity which is inhibited the cellular adhesion or hiv method of inhibition of the adhesion leukocytes to endothelial cells at treatment of the illnesses caused by it method of treatment of the mammalian infected hiv | |
ES2173858T3 (es) | Analogos de huperzina a. | |
EE04044B1 (et) | Farmatseutilised tooted veresoonte endoteelirakkude kahjustuste tagajärjel tekkinud haiguste raviksja vältimiseks | |
NO943126D0 (no) | 3-alkyloksy-, aryloksy- eller arylalkyloksybenzo-[bÅtiofen-2-karboksamider som hemmere av celleadhesjon | |
DE69819922D1 (de) | 2-Amino-6-methyl-7-acetyl-tetralin und pharmazeutische Zusammensetzungen zur Vorbeugung und therapeutischen Behandlung von entzündlichen und/oder Autoimmunkrankheiten | |
FR2378855A1 (fr) | Nouvelles glycoproteines isolees d'hafnia, procede de preparation et application a titre de medicaments | |
DE69433110D1 (de) | Allogenes vakzin und synthesemethode für selbiges | |
DE59108104D1 (de) | Arzneimittel enthaltend cd14 | |
RU93058322A (ru) | Композиции для предотвращения и/или лечения патологических процессов, способ применения низкомолекулярного гепарина, способ лечения | |
YU107692A (sh) | Sulfonamidi i postupak za njihovo dobijanje | |
Cohen et al. | Methods of using low molecular weight heparins treatment of pathological processes | |
SE8306792D0 (sv) | Neues terapeutisches preparat enthaltend hydrierte ergotalkaloide und heparin | |
Morales et al. | Experimental immunotherapy with NK-like cells: A preliminary report | |
Gallily et al. | Mouse macrophage functions under the influence of factors released by spleen cells preincubated with the methanol extraction residue (MER) tubercle bacillus fraction | |
Pintucci et al. | Cathepsin G, a polymorphonuclear cell protease, is able to affect fibrinolytic system by releasing PAI-1 from endothelial cells | |
RU97117918A (ru) | Способ адаптивной иммунотерапии злокачественных новообразований |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |